Results 81 to 90 of about 1,673 (95)

Productivity Improvement of Human Papillomavirus-like Particles in Insect Cells Using Hyper-Expression Baculovirus Vector. [PDF]

Vaccines (Basel)
Choi JB, Lee JH, Kim EH, Kim JD, Kim SY, Oh JM, Woo SD, Kim H, Han BK.   +8 more
europepmc   +1 more source

Vaccine Adjuvants and Delivery Systems: A Comprehensive Review. [PDF]

Int J Mol Sci
García AH, De Sanctis JB.
europepmc   +1 more source

Cell-Mediated Immunity Against Human Papillomavirus Infection: From Viral Clearance to Oncogenesis. [PDF]

Viruses
Savage D, Hu J, Burgener AD, Raouf A, Murooka TT.   +4 more
europepmc   +1 more source

From bench to bedside: Unveiling the background and benefits of nanovaccines tested in clinics. [PDF]

Asian J Pharm Sci
Egorova VS, Kolesova EP, Voronina MV, Denisova ER, Syrocheva AO, Pallaeva T, Hakemi MG, Zamyatnin AA, Ivanov KI, Kostyushev D, Brezgin S, Kostyusheva A, Parodi A.   +12 more
europepmc   +1 more source

Human Papillomavirus-Related Cancer Vaccine Strategies. [PDF]

Vaccines (Basel)
Cai X, Xu L.
europepmc   +1 more source

Advancing the elimination of cervical cancer across Africa. [PDF]

Nat Commun
Osafo KS, Zhang Y, Obiri-Yeboah D, Sun B, Yang H, Sun P.   +5 more
europepmc   +1 more source

Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting. [PDF]

J Gynecol Oncol
Termrungruanglert W, Khemapech N, Vasuratna A, Havanond P, Tantitamit T.   +4 more
europepmc   +1 more source

Immunopersistence of one or two doses of an Escherichia coli produced bivalent HPV vaccine. [PDF]

NPJ Vaccines
Liao M, Quan J, Zhu K, Hu X, Shen S, Xu J, Nie C, Xu W, Jiang H, Wu X, Zhong Y, Peng Y, Cai S, Chen J, Zhang C, Lin B, Su Y, Huang S, Chen Q, Wu T, Zhang J, Xia N.   +21 more
europepmc   +1 more source

IAPSM's Position Paper on the Human Papilloma Virus (HPV) Vaccine for Adult Immunization in India. [PDF]

Indian J Community Med
Shetty RS, Nadda A, Tambe M, Raut A, Goel K, Rao CR, Mehta A, Bhardwaj P, Gupta M, Kamath VG.   +9 more
europepmc   +1 more source

Efficacy, effectiveness and immunogenicity of reduced HPV vaccination schedules: A review of available evidence. [PDF]

Can Commun Dis Rep
Montroy J, Salvadori MI, Forbes N, Dubey V, Almasri S, Jirovec A, Yan C, Gusic K, Stevens A, Young K, Tunis M.   +10 more
europepmc   +1 more source